Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosa Faner

Showing results (11-20 of 169) with videos related to

Pageof 17
Sort By:
The Lancet. Global Health|April 20, 2019
Global lung health: the dangers of mild lung function impairmentRosa Faner, Alvar Agusti
American Journal of Respiratory and Critical Care Medicine|July 19, 2018
How to Define Early Chronic Obstructive Pulmonary DiseaseAlvar Agusti, Rosa Faner
Respirology (Carlton, Vic.)|February 24, 2022
CT in COPD: To be or not to beAlvar Agusti, Rosa Faner
Clinics in Chest Medicine|August 18, 2020
Chronic Obstructive Pulmonary Disease PathogenesisAlvar Agusti, Rosa Faner
Presse Medicale (Paris, France : 1983)|October 31, 2025
Personalizing COPD care: Phenotypes, endotypes, GETomics, the trajectome, syndemics and treatable traitsAlvar Agusti, Rosa Faner
Annals of the American Thoracic Society|December 23, 2016
Multilevel, Dynamic Chronic Obstructive Pulmonary Disease Heterogeneity. A Challenge for Personalized MedicineRosa Faner, Álvar Agustí
Expert Review of Clinical Immunology|September 28, 2013
Immune response in chronic obstructive pulmonary diseaseRosa Faner, Tamara Cruz, Alvar Agusti
American Journal of Physiology. Lung Cellular and Molecular Physiology|September 23, 2020
COPD 2020: changes and challengesAlvar Agustí, Claus Vogelmeier, Rosa Faner
The Lancet. Respiratory Medicine|April 12, 2021
Early treatment with inhaled budesonide to prevent clinical deterioration in patients with COVID-19Alvar Agusti, Ferran Torres, Rosa Faner
Respirology (Carlton, Vic.)|July 15, 2015
Biomarkers, the control panel and personalized COPD medicineAlvar Agusti, Joaquim Gea, Rosa Faner
Pageof 17

Showing results (11-20 of 169) with videos related to

Sort By:
Pageof 17
The Lancet. Global Health|April 20, 2019
Global lung health: the dangers of mild lung function impairmentRosa Faner, Alvar Agusti
American Journal of Respiratory and Critical Care Medicine|July 19, 2018
How to Define Early Chronic Obstructive Pulmonary DiseaseAlvar Agusti, Rosa Faner
Respirology (Carlton, Vic.)|February 24, 2022
CT in COPD: To be or not to beAlvar Agusti, Rosa Faner
Clinics in Chest Medicine|August 18, 2020
Chronic Obstructive Pulmonary Disease PathogenesisAlvar Agusti, Rosa Faner
Presse Medicale (Paris, France : 1983)|October 31, 2025
Personalizing COPD care: Phenotypes, endotypes, GETomics, the trajectome, syndemics and treatable traitsAlvar Agusti, Rosa Faner
Annals of the American Thoracic Society|December 23, 2016
Multilevel, Dynamic Chronic Obstructive Pulmonary Disease Heterogeneity. A Challenge for Personalized MedicineRosa Faner, Álvar Agustí
Expert Review of Clinical Immunology|September 28, 2013
Immune response in chronic obstructive pulmonary diseaseRosa Faner, Tamara Cruz, Alvar Agusti
American Journal of Physiology. Lung Cellular and Molecular Physiology|September 23, 2020
COPD 2020: changes and challengesAlvar Agustí, Claus Vogelmeier, Rosa Faner
The Lancet. Respiratory Medicine|April 12, 2021
Early treatment with inhaled budesonide to prevent clinical deterioration in patients with COVID-19Alvar Agusti, Ferran Torres, Rosa Faner
Respirology (Carlton, Vic.)|July 15, 2015
Biomarkers, the control panel and personalized COPD medicineAlvar Agusti, Joaquim Gea, Rosa Faner
Pageof 17